← Medication Database
Other Specialties

Zelnorm

Generic: tegaserod

Manufacturer: Alfasigma USA  ·  Program:

Apply for Assistance

Eligibility Criteria

Insurance Requirement

See program details

Residency

US residency required

Program Information

Processing Time

2–4 weeks

Delivery Method

Varies by program

Application Method

Online

Indicated For

irritable bowel syndrome with constipation (IBS-C)

About This Medication

# Zelnorm Patient Assistance Program Guide: How to Get Zelnorm at Low or No Cost **Important Notice:** As of recent updates, Alfasigma USA, the manufacturer of Zelnorm (tegaserod), has withdrawn the medication from the U.S. market. This is a business decision unrelated to safety or efficacy, and limited supplies may still be available for current patients.[9] Patient assistance programs are typically offered by manufacturers, but no specific Zelnorm program details are publicly available from Alfasigma USA. This guide provides general information on how such programs work, what to expect, and next steps while directing you to contact the manufacturer directly for the latest options.[8] ## About Zelnorm (Tegaserod) Zelnorm is a prescription medication approved by the FDA for treating **irritable bowel syndrome with constipation (IBS-C)** in adult women under 65 years of age. It works as a selective serotonin-4 (5-HT4) receptor agonist, targeting neurons and smooth muscle cells in the gastrointestinal tract to promote bowel contractions, relaxation, and reduced pain signaling.[1][2][4] The typical dose is 6 mg tablets taken orally twice daily, at least 30 minutes before meals.[2] Originally approved in 2002, Zelnorm was withdrawn in 2007 due to cardiovascular concerns but reapproved in 2019 for the specified population after FDA review of clinical data.[3][4] It's not indicated for men with IBS-C, as safety and effectiveness have not been established.[1] Key warnings include risks of myocardial infarction, stroke, transient ischemic attack, angina, severe diarrhea, hypotension, syncope, and suicidal ideation—discontinue use and contact your doctor if these occur.[2] **Who Should Not Take Zelnorm?** Avoid if you have a history of heart problems, are pregnant, or experience inadequate symptom control after 4-6 weeks.[2][6] ## Who Qualifies for Patient Assistance? Manufacturer patient assistance programs (PAPs) help uninsured or underinsured patients afford medications. Since specific details for Zelnorm's program are unavailable (e.g., no listed income thresholds, application methods, or phone numbers), eligibility generally follows industry standards: - **Medical Eligibility:** FDA-approved use (women <65 with IBS-C), prescribed by a licensed U.S. healthcare provider.[1][2] - **Financial Need:** Household income typically at or below 400-500% of the Federal Poverty Level (FPL). For 2026, this might mean: | Household Size | Income Threshold (Estimated 400% FPL) | |---------------|--------------------------------------| | 1 (Individual)| ~$60,000/year | | 2 (Couple) | ~$81,000/year | | 3 | ~$102,000/year | | 4 | ~$123,000/year | *Note: These are general estimates; actual thresholds vary and are not confirmed for Zelnorm. No specific FPL percent or notes available.*[7] - **U.S. Residency:** Must live in the U.S. and have a valid prescription. Contact Alfasigma USA for exact criteria, as programs evolve.[8] ## Insurance Requirements Most PAPs require you to be uninsured or have insurance that doesn't cover Zelnorm (e.g., high copays). Medicare Part D patients may qualify if they hit the "coverage gap" or fail step therapy. Commercial insurance often needs prior authorization (PA) proving IBS-C diagnosis and female patient <65.[1][6] Submit proof of denial or coverage details. Medicaid patients rarely qualify, as government insurance typically excludes PAPs.[7] ## Step-by-Step Application Process 1. **Consult Your Doctor:** Get a prescription and diagnosis confirmation for IBS-C. Discuss if Zelnorm is right, given market withdrawal.[1][2] 2. **Check Availability:** Call Alfasigma USA (visit alfasigmausa.com for contacts) to confirm if any PAP exists post-withdrawal.[8][9] 3. **Gather Documents:** Typically proof of income (tax returns, pay stubs), prescription, doctor's statement, insurance card/denial.[7] 4. **Apply:** Online, mail, or phone—details unavailable, so request from manufacturer. 5. **Wait for Approval:** Processing varies (see FAQ). 6. **Receive Medication:** Shipped to doctor or home. ## Timeline and Delivery Approval can take 2-4 weeks generally, but call for updates. Medication ships free via mail or pharmacy.[7] With market withdrawal, supply is limited—act quickly.[9] ## Alternatives if Denied or Unavailable - **Generic Options:** None available.[9] - **Other IBS-C Treatments:** Linaclotide (Linzess), lubiprostone (Amitiza), plecanatide (Trulance)—check their PAPs. - **General Resources:** NeedyMeds.org, RxAssist.org, Partnership for Prescription Assistance. - **Clinical Trials:** Search ClinicalTrials.gov for IBS-C studies. ## Disclaimer This guide is for informational purposes only and not medical or financial advice. Zelnorm's market status may change; verify with Alfasigma USA or FDA. Consult your healthcare provider before starting/stopping treatment. Program details are unavailable in public sources, so contact manufacturer directly. Word count: ~950.

Program information last verified: March 30, 2026

Ready to apply for Zelnorm assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications